The collaboration with Sandoz bolsters Vectura’s already substantial portfolio of generics programmes in development. The generics segment is an important and fast-growing segment of the US respiratory market, representing c. 80% of the prescription volume but only c. 13% by market value. With multiple feasibility studies underway at Vectura, we believe further collaboration agreements in the generics space are likely. However, the VR315 (generic Advair®) uncertainty in the US continues to weigh ....
29 Jun 2017
N+1 Singer - Vectura Group - Collaboration agreement with Sandoz bolsters generics pipeline
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Vectura Group - Collaboration agreement with Sandoz bolsters generics pipeline
- Published:
29 Jun 2017 -
Author:
Dr Jens Lindqvist -
Pages:
3
The collaboration with Sandoz bolsters Vectura’s already substantial portfolio of generics programmes in development. The generics segment is an important and fast-growing segment of the US respiratory market, representing c. 80% of the prescription volume but only c. 13% by market value. With multiple feasibility studies underway at Vectura, we believe further collaboration agreements in the generics space are likely. However, the VR315 (generic Advair®) uncertainty in the US continues to weigh ....